Abstract |
Severe acute respiratory syndrome (SARS) is an acute infectious disease with significant mortality. A typical clinical feature associated with SARS is pulmonary fibrosis and the associated lung failure. However, the underlying mechanism remains elusive. In this study, we demonstrate that SARS-associated coronavirus (SARS-CoV) nucleocapsid (N) protein potentiates transforming growth factor-beta ( TGF-beta)-induced expression of plasminogen activator inhibitor-1 but attenuates Smad3/Smad4-mediated apoptosis of human peripheral lung epithelial HPL1 cells. The promoting effect of N protein on the transcriptional responses of TGF-beta is Smad3-specific. N protein associates with Smad3 and promotes Smad3-p300 complex formation while it interferes with the complex formation between Smad3 and Smad4. These findings provide evidence of a novel mechanism whereby N protein modulates TGF-beta signaling to block apoptosis of SARS-CoV-infected host cells and meanwhile promote tissue fibrosis. Our results reveal a novel mode of Smad3 action in a Smad4-independent manner and may lead to successful strategies for SARS treatment by targeting the TGF-beta signaling molecules.
|
Authors | Xingang Zhao, John M Nicholls, Ye-Guang Chen |
Journal | The Journal of biological chemistry
(J Biol Chem)
Vol. 283
Issue 6
Pg. 3272-3280
(Feb 08 2008)
ISSN: 0021-9258 [Print] United States |
PMID | 18055455
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Nucleocapsid Proteins
- Smad3 Protein
- Smad4 Protein
- Transforming Growth Factor beta
|
Topics |
- Animals
- Apoptosis
- Cell Line
- Fibrosis
(pathology)
- Gene Expression Regulation, Viral
- Humans
- Mice
- Nucleocapsid Proteins
(metabolism)
- Protein Binding
- Protein Structure, Tertiary
- Severe acute respiratory syndrome-related coronavirus
(metabolism)
- Signal Transduction
- Smad3 Protein
(metabolism)
- Smad4 Protein
(metabolism)
- Transforming Growth Factor beta
(metabolism)
|